Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 189
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Dermatology AI Assistant to Empower Primary Care Providers in Zaatari Refugee Camp in Jordan

An AI-assisted dermatology tool for refugees, utilizing imaging and symptom questionnaires to improve diagnostic...

Can we make anesthesia for dogs safer with the help of nutrition?

Hypothermia, low body temperature, is one of the most common complications of anesthesia and can result...

Dicty World Race - finding the fastest and smartest Dicty cells

On May 16, Dicty and HL60 cells will race for the "fastest &smartest" title. Both cell types are models...

Backer Badge Funded